New combo therapy tested for stubborn IBS symptoms
NCT ID NCT06684470
Summary
This Mayo Clinic study is testing if adding the medication mirtazapine to a low-FODMAP diet helps people with IBS-D feel better than using the diet alone. The low-FODMAP diet avoids certain hard-to-digest carbs. Researchers want to see if the combination reduces abdominal pain, diarrhea, and bloating more effectively for the 20 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBS - IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic
RECRUITINGJacksonville, Florida, 32224, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.